T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-γ expression

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 1036-1045

  Long, Meixiao ^a   Slaiby, Aaron M ^a   Hagymasi, Adam T ^a   Mihalyo, Marianne A ^a   Lichtler, Alexander C ^a   Reiner, Steven L ^b   Adler, Adam J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

ACETYLATION; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHROMATIN STRUCTURE; EFFECTOR CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSCRIPTION REGULATION;

EID: 30744457828     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.1036     Document Type: Article

References (52)

1. Kappler, J., M. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280.
2. + thymocytes. Nature 333: 742-746.
3. Sebzda, E., V. A. Wallace, J. Mayer, R. S. Yeung, T. W. Mak, and P. S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263: 1615-1618.
4. Surh, C. D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103.
5. Jones, L. A., L. T. Chin, D. L. Longo, and A. M. Kruisbeek. 1990. Peripheral clonal elimination of functional T cells. Science 250: 1726-1729.
6. + T cells. Int. Immunol. 4: 599-610.
7. + antigen-specific T cells after in vivo exposure to male antigen. J. Immunol. 148: 3740-3745.
8. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
9. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458.
10. + suppressor T cells. J. Exp. Med. 193: F41-F46.
11. Higgins, A. D., M. A. Mihalyo, and A. J. Adler. 2002. Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen. J. Immunol. 169: 3622-3629.
12. + T cells undergo peripheral tolerance. Immunity 17: 73-81.
13. Oldstone, M. B. 1998. Molecular mimicry and immune-mediated diseases. FASEB J. 12: 1255-1265.
14. Mihalyo, M. A., A. D. Doody, J. P. McAleer, E. C. Nowak, M. Long, Y. Yang, and A. J. Adler. 2004. In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy. J. Immunol. 172: 5338-5345.
15. Adler, A. J. 2005. Peripheral tolerization of effector and memory T cells: implications for autoimmunity and tumor-immunity. Curr. Immunol. Rev. 1: 21-28.
16. Long, M., A. D. Higgins, M. A. Mihalyo, and A. J. Adler. 2003. Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-α and IFN-γ expression potentials. Cell. Immunol. 224: 114-121.
17. Yang, X. D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180: 995-1004.
18. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNF α in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454.
19. von Herrath, M. G., and M. B. Oldstone. 1997. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185: 531-539.
20. Seewaldt, S., H. E. Thomas, M. Ejrnaes, U. Christen, T. Wolfe, E. Rodrigo, B. Coon, B. Michelsen, T. W. Kay, and M. G. von Herrath. 2000. Virus-induced autoimmune diabetes: most β-cells die through inflammatory cytokines and not perforin from autoreactive (antiviral) cytotoxic T-lymphocytes. Diabetes 49: 1801-1809.
21. + T cells in the antitumor immune response. J. Exp. Med. 188: 2357-2368.
22. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN γ receptor expression by nonhematopoietic cells. Immunity 12: 677-686.
23. Ikeda, H., L. J. Old, and R. D. Schreiber. 2002. The roles of IFN γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13: 95-109.
24. Poehlein, C. H., H. M. Hu, J. Yamada, I. Assmann, W. G. Alvord, W. J. Urba, and B. A. Fox. 2003. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-γ double knockout effector T cells. J. Immunol. 170: 2004-2013.
25. Winter, H., H. M. Hu, K. McClain, W. J. Urba, and B. A. Fox. 2001. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-γ in vaccine-induced antitumor immunity versus adoptive immunotherapy. J. Immunol. 166: 7370-7380.
26. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
27. Mullen, A. C., F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292: 1907-1910.
28. H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3: 643-651.
29. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
30. + T cells. Nat. Immunol. 3: 549-557.
31. + single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34.
32. Higgins, A. D., M. A. Mihalyo, P. W. McGary, and A. J. Adler. 2002. CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement. J. Immunol. 168: 5573-5581.
33. H1 gene induction. Nat. Immunol. 3: 652-658.
34. + T cell tolerance induction versus priming is independent of the rate and number of cell divisions. J. Immunol. 164: 649-655.
35. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29: 548-555.
36. Fields, P. E., S. T. Kim, and R. A. Flavell. 2002. Cutting edge: changes in histone acetylation at the IL-4 and IFN-γ loci accompany Th1/Th2 differentiation. J. Immunol. 169: 647-650.
37. Cho, J. Y., V. Grigura, T. L. Murphy, and K. Murphy. 2003. Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-γ promoter. Int. Immunol. 15: 1149-1160.
38. Lovett-Racke, A. E., A. E. Rocchini, J. Choy, S. C. Northrop, R. Z. Hussain, R. B. Ratts, D. Sikder, and M. K. Racke. 2004. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21: 719-731.
39. Tong, Y., T. Aune, and M. Boothby. 2005. T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-γ promoter via a conserved T-box half-site. Proc. Natl. Acad. Sci. USA 102: 2034-2039.
40. Sasaki, Y., K. Ihara, N. Matsuura, H. Kohno, S. Nagafuchi, R. Kuromaru, K. Kusuhara, R. Takeya, T. Hoey, H. Sumimoto, and T. Hara. 2004. Identification of a novel type 1 diabetes susceptibility gene, T-bet. Hum. Genet. 115: 177-184.
41. Bird, J. J., D. R. Brown, A. C. Mullen, N. H. Moskowitz, M. A. Mahowald, J. R. Sider, T. F. Gajewski, C. R. Wang, and S. L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9: 229-237.
42. Agarwal, S., and A. Rao. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9: 765-775.
43. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339.
44. + T cells. J. Exp. Med. 185: 405-414.
45. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen presenting cells. J. Exp. Med. 187: 1555-1564.
46. LaSalle, J. M., P. J. Tolentino, G. J. Freeman, L. M. Nadler, and D. A. Hafler. 1992. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J. Exp. Med. 176: 177-186.
47. fyn. J. Immunol. 149: 2887-2893.
48. + T cells. Science 271: 1272-1276.
49. + T cells. Science 271: 1276-1278.
50. Macian, F., F. Garcia-Cozar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731.
51. McKay, D. B., H. Y. Irie, G. Hollander, J. L. Ferrara, T. B. Strom, Y. Li, and S. J. Burakoff. 1999. Antigen-induced unresponsiveness results in altered T cell signaling. J. Immunol. 163: 6455-6461.
52. Lathrop, S. K., C. A. Huddleston, P. A. Dullforce, M. J. Montfort, A. D. Weinberg, and D. C. Parker. 2004. A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions. J. Immunol. 172: 6735-6743.